MWM
GOSS icon

Merriman Wealth Management’s Gossamer Bio GOSS Stock Holding History

Merriman Wealth Management’s Portfolio GOSS Stock Details GOSS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		$129K Buy
+1,778
New +$122K 0.01% 205

Other funds holding GOSS

OCA
Octagon Capital Advisors New York $1.11B AUM 866.76% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $1.1B AUM 356.62% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return
SCM
Silverarc Capital Management Boston, Massachusetts $962M AUM 524.64% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.22B AUM 242.83% 1-Year Est. Return

Merriman Wealth Management's GOSS Position: Q4 2024 in Review

Merriman Wealth Management opened a new position in Gossamer Bio (GOSS) in Q4 2024: 1,778 shares worth $129K. The stake represents 0.01% of the portfolio and ranks #205 among its holdings.

102 funds tracked by Wall St. Rank hold GOSS as of Q4 2024.

  • Merriman Wealth Management held 1,778 shares of Gossamer Bio worth $129K as of Q4 2024.
  • Gossamer Bio was a new Merriman Wealth Management position in Q4 2024.
  • Gossamer Bio made up 0.01% of Merriman Wealth Management's portfolio in Q4 2024, its #205 holding.
  • 102 funds tracked by Wall St. Rank held Gossamer Bio as of Q4 2024.

Based on Merriman Wealth Management's 13F filing for Q4 2024, filed 13 Feb 2025.